|
US2694711A
(en)
|
1952-12-02 |
1954-11-16 |
American Cyanamid Co |
Quinazolone antimalarial compounds
|
|
US6008217A
(en)
*
|
1995-12-20 |
1999-12-28 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of interleukin-1β converting enzyme
|
|
US6204261B1
(en)
*
|
1995-12-20 |
2001-03-20 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of interleukin-1β Converting enzyme inhibitors
|
|
DE19642451A1
(de)
|
1996-10-15 |
1998-04-16 |
Merck Patent Gmbh |
Aminothiophencarbonsäureamide
|
|
WO2004085382A1
(ja)
|
2003-03-27 |
2004-10-07 |
Kirin Beer Kabushiki Kaisha |
生体内リン輸送を阻害する化合物およびそれを含んでなる医薬
|
|
WO2006008545A2
(en)
|
2004-07-22 |
2006-01-26 |
Astex Therapeutics Limited |
Thiazole and isothiazole derivatives as protein kinase inhibitors
|
|
US20070010537A1
(en)
|
2004-08-20 |
2007-01-11 |
Kazumasa Hamamura |
Fused pyramidine derivative and use thereof
|
|
EP1896476A2
(en)
|
2005-06-28 |
2008-03-12 |
Orchid Research Laboratories Limited |
Novel pyrazolopyrimidinone derivatives
|
|
GB0513702D0
(en)
|
2005-07-04 |
2005-08-10 |
Sterix Ltd |
Compound
|
|
CN101287728A
(zh)
|
2005-08-17 |
2008-10-15 |
先灵公司 |
新的高亲和力噻吩基和呋喃基激酶配体
|
|
DK2428513T3
(en)
|
2006-09-26 |
2017-08-21 |
Celgene Corp |
5-substituted quinazolinone derivatives as anti-cancer agents
|
|
US20080255161A1
(en)
*
|
2007-04-11 |
2008-10-16 |
Dmitry Koltun |
3-HYDROQUINAZOLIN-4-ONE DERIVATIVES FOR USE AS STEAROYL CoA DESATURASE INHIBITORS
|
|
US8703768B2
(en)
|
2010-06-09 |
2014-04-22 |
Hoffmann-La Roche Inc. |
Nitrogen containing heteroaryl compounds
|
|
US20120165330A1
(en)
*
|
2010-12-22 |
2012-06-28 |
Sirtris Pharmaceuticals, Inc. |
Quinazolinone and related analogs as sirtuin modulators
|
|
CN103288771B
(zh)
|
2012-02-29 |
2014-12-03 |
中国中化股份有限公司 |
异噻唑类化合物及其作为杀菌剂的用途
|
|
WO2013165606A1
(en)
|
2012-05-04 |
2013-11-07 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Modulators of the relaxin receptor 1
|
|
CA2935495C
(en)
|
2013-01-14 |
2021-04-20 |
Deuterx, Llc |
3-(5-substituted-4-oxoquinazolin-3(4h)-yl)-3-deutero-piperidine-2,6-dione derivatives
|
|
CN105524053B
(zh)
|
2014-10-19 |
2020-06-05 |
广东东阳光药业有限公司 |
四氢苯并噻吩化合物
|
|
EP3804725A3
(en)
|
2014-11-17 |
2021-07-07 |
Rhode Island Hospital |
Nanomaterial compositions, synthesis, and assembly
|
|
DK3356345T3
(da)
|
2015-09-30 |
2024-02-12 |
Max Planck Gesellschaft |
Heteroaryl-derivater som sepiapterin-reduktase-inhibitorer
|
|
EP3404024B1
(en)
|
2016-01-14 |
2020-11-18 |
Kangpu Biopharmaceuticals, Ltd. |
Quinazolinone derivative, preparation method therefor, pharmaceutical composition, and applications
|
|
KR101870968B1
(ko)
|
2016-02-02 |
2018-06-25 |
부산대학교 산학협력단 |
Ppar, fxr 및 ampk 활성화 효능을 갖는 신규 티오펜 화합물 또는 이의 약제학적으로 허용 가능한 염 및 이의 의학적 용도
|
|
SI3497091T1
(sl)
|
2016-08-15 |
2020-11-30 |
Eli Lilly And Company |
Kondenzirani derivati tiofena uporabni kot inhibitorji NAPI-IIB
|
|
TWI762634B
(zh)
|
2017-05-05 |
2022-05-01 |
大陸商上海赫普化醫藥技術有限公司 |
胺基-芳基-苯甲醯胺化合物及其使用方法
|
|
BR112020015743A2
(pt)
|
2018-02-08 |
2020-12-15 |
Enyo Pharma |
Derivados de tiofeno não fundido e seus usos
|
|
AU2019240214A1
(en)
|
2018-03-21 |
2020-09-17 |
Ionis Pharmaceuticals, Inc. |
Modulation of HSD17B13 expression
|
|
CA3110520A1
(en)
|
2018-08-24 |
2020-02-27 |
Terns, Inc. |
Thyroid hormone receptor beta agonist compounds
|
|
EP3994125B1
(en)
|
2019-07-02 |
2025-12-24 |
Regeneron Pharmaceuticals, Inc. |
Modulators of hsd17b13 and methods of use thereof
|
|
WO2021211974A1
(en)
|
2020-04-18 |
2021-10-21 |
Inipharm, Inc. |
Hsd17b13 inhibitors and uses thereof
|
|
WO2022020714A1
(en)
|
2020-07-24 |
2022-01-27 |
Inipharm, Inc. |
Thiophene hsd17b13 inhibitors and uses thereof
|
|
EP4185380A4
(en)
|
2020-07-24 |
2024-08-21 |
Inipharm, Inc. |
Quinazolinone hsd17b13 inhibitors and uses thereof
|
|
EP4192448A1
(en)
|
2020-08-05 |
2023-06-14 |
ENYO Pharma |
Thiophen compounds for use in the treatment of renal fibrosis
|
|
WO2022040324A1
(en)
|
2020-08-18 |
2022-02-24 |
Metrea Biosciences, Inc. |
COMPOUNDS AND METHODS OF MODULATING 17β-ΗYDROXYSTEROID DEHYDROGENASE TYPE 13
|
|
IL301768A
(en)
|
2020-09-30 |
2023-05-01 |
Fl2022 001 Inc |
Hsd17b13 inhibitors and uses thereof
|
|
US20240083853A1
(en)
|
2020-09-30 |
2024-03-14 |
Fl2022-001, Inc. |
Hsd17b13 inhibitors and uses thereof
|
|
CA3194376A1
(en)
|
2020-09-30 |
2022-04-07 |
Andrew R. Hudson |
Hsd17b13 inhibitors and uses thereof
|
|
US20230416802A1
(en)
|
2020-11-06 |
2023-12-28 |
Inipharm, Inc. |
Specific substrates and products of hsd17b13 as markers of liver disease and biomarkers for liver disease treatment
|
|
CN116670118B
(zh)
|
2020-11-13 |
2026-02-06 |
伊尼制药公司 |
二氯苯酚hsd17b13抑制剂及其用途
|
|
WO2022216627A1
(en)
|
2021-04-05 |
2022-10-13 |
Inipharm, Inc. |
Thiazole/isothiazole hsd17b13 inhibitors and uses thereof
|
|
EP4320111A4
(en)
|
2021-04-05 |
2025-03-12 |
Inipharm, Inc. |
HYDROXYPYRIDINE-TYPE HSD17B13 INHIBITORS AND USES THEREOF
|
|
CN118103038A
(zh)
|
2021-08-20 |
2024-05-28 |
英安塔制药有限公司 |
17β-羟基类固醇脱氢酶13型抑制剂及其使用方法
|
|
JP2025503953A
(ja)
|
2022-01-26 |
2025-02-06 |
イニファーム，インク． |
２－置換チアゾールｈｓｄ１７ｂ１３阻害剤およびその使用
|
|
JP2025523357A
(ja)
|
2022-06-09 |
2025-07-23 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
Ｈｓｄ１７ｂ１３阻害剤
|